Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Automated Microbial Diagnostics01:24

Automated Microbial Diagnostics

Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Trichomoniasis01:18

Trichomoniasis

Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-read transcriptomics corrects Trichomonas vaginalis intron annotations and refines transcript-end features.

Parasites & vectors·2026
Same author

A Vascularized Bone-on-Paper Platform To Study Periosteum-Vascular Crosstalk and Angiogenic Remodeling.

Analytical chemistry·2026
Same author

MsTargetPeaker: A Quality-Aware Deep Reinforcement Learning Approach for Peak Identification in Targeted Proteomics.

Molecular & cellular proteomics : MCP·2026
Same author

Viral load dependent cellular heterogeneity in Trichomonas vaginalis at the single cell level.

iScience·2026
Same author

Comparative genomics of the parasite Trichomonas vaginalis reveals genes involved in spillover from birds to humans.

Nature communications·2025
Same author

Biomicrofluidic innovations and applications in precision medicine: Highlights from IEEE-NANOMED2023.

Biomicrofluidics·2025

Related Experiment Video

Updated: Jun 18, 2026

Artificial Intelligence Approaches to Assessing Primary Cilia
08:58

Artificial Intelligence Approaches to Assessing Primary Cilia

Published on: May 1, 2021

4.1K

Microfluidic-Based Analysis of Trichomonas Vaginalis Attachment and Drug Response Using AI-Based Imaging Algorithm.

Kin Fong Lei1,2,3, Boreddy Sai Kiran Reddy1, Hong-Wei Luo4

  • 1Department of Biomedical Engineering, Chang Gung University, Taoyuan, Taiwan.

Advanced Biology
|January 10, 2026
PubMed
Summary

A novel microfluidic platform with AI analysis effectively quantifies Trichomonas vaginalis attachment and drug efficacy. Combination therapy showed superior results for treating this common STI, indicating potential synergistic effects.

Keywords:
AI‐based imagingT. vaginalisdrug screeningmicrofluidicsparasite attachment

More Related Videos

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

2.4K
Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip
08:15

Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip

Published on: February 16, 2024

3.2K

Related Experiment Videos

Last Updated: Jun 18, 2026

Artificial Intelligence Approaches to Assessing Primary Cilia
08:58

Artificial Intelligence Approaches to Assessing Primary Cilia

Published on: May 1, 2021

4.1K
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
08:20

Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images

Published on: October 27, 2023

2.4K
Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip
08:15

Author Spotlight: Revolutionizing Research on Vaginal Microbiome Interactions Using a Vaginal Chip

Published on: February 16, 2024

3.2K

Area of Science:

  • Parasitology
  • Biotechnology
  • Infectious Diseases

Background:

  • Trichomonas vaginalis causes the most common non-viral sexually transmitted infection globally.
  • Rising drug resistance necessitates novel therapeutic evaluation methods.
  • Current drug screening methods lack efficiency for complex parasitic interactions.

Purpose of the Study:

  • To develop and validate a microfluidic culture platform integrated with AI for assessing T. vaginalis drug efficacy.
  • To quantify parasite attachment dynamics under various drug treatments.
  • To evaluate the efficacy of single and combination therapies against T. vaginalis.

Main Methods:

  • Development of a microfluidic platform for controlled T. vaginalis exposure to host cells (HeLa, BFTC905).
  • Integration of an AI-based imaging algorithm for real-time parasite attachment quantification.
  • Application of spatial color-coded map analysis for drug gradient assessment.

Main Results:

  • Metronidazole significantly reduced T. vaginalis attachment in a dose-dependent manner.
  • Combination therapy (metronidazole and paromomycin) demonstrated superior inhibitory effects compared to single drugs.
  • The microfluidic-AI system provided robust and reproducible results across different cell lines.

Conclusions:

  • Combination therapy holds promise for managing T. vaginalis infections due to potential synergistic interactions.
  • The microfluidic-AI system is a valuable tool for high-throughput anti-parasitic drug screening and development.
  • This technology advances therapeutic evaluation for sexually transmitted infections.